Nebulized dexamethasone sodium phosphate in the treatment of horses with severe asthma

Abstract Background A study reported low systemic availability of injectable dexamethasone nebulized to healthy horses using the Flexineb mask. When used in horses with severe asthma and a different nebulizer, lack of efficacy and cortisol suppression were observed. Hypothesis Nebulized dexamethason...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Selena deWasseige, Khristine Picotte, Jean‐Pierre Lavoie
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/c9dcda3be03640c7bf30ef53e11d7340
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c9dcda3be03640c7bf30ef53e11d7340
record_format dspace
spelling oai:doaj.org-article:c9dcda3be03640c7bf30ef53e11d73402021-11-30T17:01:05ZNebulized dexamethasone sodium phosphate in the treatment of horses with severe asthma1939-16760891-664010.1111/jvim.16113https://doaj.org/article/c9dcda3be03640c7bf30ef53e11d73402021-05-01T00:00:00Zhttps://doi.org/10.1111/jvim.16113https://doaj.org/toc/0891-6640https://doaj.org/toc/1939-1676Abstract Background A study reported low systemic availability of injectable dexamethasone nebulized to healthy horses using the Flexineb mask. When used in horses with severe asthma and a different nebulizer, lack of efficacy and cortisol suppression were observed. Hypothesis Nebulized dexamethasone is as effective as PO administration for the treatment of severe asthma in horses. Animals Twelve horses with severe asthma from a research herd. Methods Randomized clinical trial. Horses were divided into 2 groups and received 5 mg of dexamethasone sodium phosphate by nebulization using a Flexineb mask (NE, n = 6) or PO (OR, n = 6) q24h for 7 days. Lung function and serum cortisol concentrations were evaluated at baseline, after 4 days of treatment (D4) and 1 day after the last treatment (D8). Data were analyzed using linear mixed models with Benjamini‐Hochberg adjustments. Results Lung resistance significantly improved at D4 (mean decrease ± SD, −1.5 ± 0.45 cm H₂O/L/s; 95% confidence interval [CI], −2; −0.6) and D8 (−1.4 ± 0.45 cm H₂O/L/s; 95% CI, −2.4; −0.5) compared to baseline in the OR group only (P = .004 and .01, respectively). Serum cortisol concentration was significantly decreased at D4 and D8 for both groups (maximum decrease, −1.2 ± 0.3 μg/dL; 95% CI, −1.9; −0.6 at D4 for NE group and −2.2 ± 0.3 μg/dL; 95% CI, −2.8; −1.6 at D8 for OR group; P < .001). Conclusions and Clinical Importance Oral, but not nebulized dexamethasone is an effective therapy for horses with severe asthma and both treatment modalities inhibit the hypothalamic‐pituitary‐adrenal axis.Selena deWasseigeKhristine PicotteJean‐Pierre LavoieWileyarticlecorticosteroidscortisolheaveshypothalamic‐pituitary‐adrenal axis suppressioninhalationlungVeterinary medicineSF600-1100ENJournal of Veterinary Internal Medicine, Vol 35, Iss 3, Pp 1604-1611 (2021)
institution DOAJ
collection DOAJ
language EN
topic corticosteroids
cortisol
heaves
hypothalamic‐pituitary‐adrenal axis suppression
inhalation
lung
Veterinary medicine
SF600-1100
spellingShingle corticosteroids
cortisol
heaves
hypothalamic‐pituitary‐adrenal axis suppression
inhalation
lung
Veterinary medicine
SF600-1100
Selena deWasseige
Khristine Picotte
Jean‐Pierre Lavoie
Nebulized dexamethasone sodium phosphate in the treatment of horses with severe asthma
description Abstract Background A study reported low systemic availability of injectable dexamethasone nebulized to healthy horses using the Flexineb mask. When used in horses with severe asthma and a different nebulizer, lack of efficacy and cortisol suppression were observed. Hypothesis Nebulized dexamethasone is as effective as PO administration for the treatment of severe asthma in horses. Animals Twelve horses with severe asthma from a research herd. Methods Randomized clinical trial. Horses were divided into 2 groups and received 5 mg of dexamethasone sodium phosphate by nebulization using a Flexineb mask (NE, n = 6) or PO (OR, n = 6) q24h for 7 days. Lung function and serum cortisol concentrations were evaluated at baseline, after 4 days of treatment (D4) and 1 day after the last treatment (D8). Data were analyzed using linear mixed models with Benjamini‐Hochberg adjustments. Results Lung resistance significantly improved at D4 (mean decrease ± SD, −1.5 ± 0.45 cm H₂O/L/s; 95% confidence interval [CI], −2; −0.6) and D8 (−1.4 ± 0.45 cm H₂O/L/s; 95% CI, −2.4; −0.5) compared to baseline in the OR group only (P = .004 and .01, respectively). Serum cortisol concentration was significantly decreased at D4 and D8 for both groups (maximum decrease, −1.2 ± 0.3 μg/dL; 95% CI, −1.9; −0.6 at D4 for NE group and −2.2 ± 0.3 μg/dL; 95% CI, −2.8; −1.6 at D8 for OR group; P < .001). Conclusions and Clinical Importance Oral, but not nebulized dexamethasone is an effective therapy for horses with severe asthma and both treatment modalities inhibit the hypothalamic‐pituitary‐adrenal axis.
format article
author Selena deWasseige
Khristine Picotte
Jean‐Pierre Lavoie
author_facet Selena deWasseige
Khristine Picotte
Jean‐Pierre Lavoie
author_sort Selena deWasseige
title Nebulized dexamethasone sodium phosphate in the treatment of horses with severe asthma
title_short Nebulized dexamethasone sodium phosphate in the treatment of horses with severe asthma
title_full Nebulized dexamethasone sodium phosphate in the treatment of horses with severe asthma
title_fullStr Nebulized dexamethasone sodium phosphate in the treatment of horses with severe asthma
title_full_unstemmed Nebulized dexamethasone sodium phosphate in the treatment of horses with severe asthma
title_sort nebulized dexamethasone sodium phosphate in the treatment of horses with severe asthma
publisher Wiley
publishDate 2021
url https://doaj.org/article/c9dcda3be03640c7bf30ef53e11d7340
work_keys_str_mv AT selenadewasseige nebulizeddexamethasonesodiumphosphateinthetreatmentofhorseswithsevereasthma
AT khristinepicotte nebulizeddexamethasonesodiumphosphateinthetreatmentofhorseswithsevereasthma
AT jeanpierrelavoie nebulizeddexamethasonesodiumphosphateinthetreatmentofhorseswithsevereasthma
_version_ 1718406471509606400